MINDCURE’s PsyCollage tool to drive decision-making for drug lead optimization and assist in the discovery of target receptors. VANCOUVER, BC, Feb. 16, 2021 /CNW/ -Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “MINDCURE” or the “Company”) is pleased to announce that it has completed beta testing of its proprietary bioinformatics platform PsyCollage, achieving its Q1 testing…


Previous articleComparing 18-MC vs. Ibogaine for the Treatment of Substance Use Disorder
Next articlePT231 – Dr. Hassan Tetteh – Human Care Over Health Care